Invention Grant
- Patent Title: (trimethoxyphenylamino) pyrimidinyl formulations
- Patent Title (中): (三甲氧基苯基氨基)嘧啶基制剂
-
Application No.: US14290494Application Date: 2014-05-29
-
Publication No.: US08951504B2Publication Date: 2015-02-10
- Inventor: Bindhumadhavan Gururajan , Farhan Abdul Karim Alhusban , Ian Paul Gabbott , Dawn Sievwright , David Bradley Brook
- Applicant: Bindhumadhavan Gururajan , Farhan Abdul Karim Alhusban , Ian Paul Gabbott , Dawn Sievwright , David Bradley Brook
- Applicant Address: US CA South San Francisco
- Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Agent Travis Young
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K9/46 ; A61K31/5383 ; A61K31/675

Abstract:
There are provided pharmaceutical compositions comprising greater than 15% w/w of a compound of Formula (I) as defined herein and/or hydrate thereof and an amount of one or more effervescent agents that is sufficient to provide satisfactory in vitro dissolution; and further comprising one or more pharmaceutically acceptable ingredients; and to processes for obtaining them.
Public/Granted literature
- US20140271493A1 (Trimethoxyphenylamino) Pyrimidinyl Formulations Public/Granted day:2014-09-18
Information query